These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6118636)

  • 1. Penicillamine-the therapeutic paradox.
    Lancet; 1981 Nov; 2(8257):1209-10. PubMed ID: 6118636
    [No Abstract]   [Full Text] [Related]  

  • 2. Some immunological changes in rheumatoid arthritis among patients receiving penicillamine and gold.
    Huskisson EC; Berry H
    Postgrad Med J; 1974 Aug; 50 Suppl 2():59-61. PubMed ID: 4467180
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Effect of penicillamine on peripheral-blood lymphocytes in rheumatoid arthritis.
    Brandt L; Svensson B
    Lancet; 1975 Feb; 1(7903):394-5. PubMed ID: 46538
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunologic abnormalities during treatment with penicillamine].
    Recordier AM; Roux H; Mercier P; Maestracci D; Schiano A
    Ann Med Interne (Paris); 1976 AUG-SEP; 127(8-9):566-70. PubMed ID: 64126
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinico-immunological analysis of D-penicillamine use in rheumatoid arthritis].
    Benenson EV; Alibekova RI; Seĭsenbaev ASh; Cherkasskiĭ LA; Ivanova RL
    Vopr Revm; 1980; (4):27-31. PubMed ID: 6972667
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of Cuprenil (penicillamine) on peripheral blood lymphocytes and their T and B populations in patients with rheumatoid arthritis].
    Małdykowa H; Brühl W; Chwalińska-Sadowska H; Grabowska A; Cygler B; Dratwianka B; Abgarowicz T; Wierzchowska E
    Reumatologia; 1978; 16(4):509-13. PubMed ID: 310147
    [No Abstract]   [Full Text] [Related]  

  • 7. [D-penicillamine in the treatment of patients with rheumatoid arthritis].
    Gracheva GV; Erov NK; Romanovskaia LR
    Ter Arkh; 1983; 55(9):94-8. PubMed ID: 6605592
    [No Abstract]   [Full Text] [Related]  

  • 8. Penicillamine in the treatment of rheumatoid arthritis.
    Camp AV
    Proc R Soc Med; 1977 Feb; 70(2):67-9. PubMed ID: 859814
    [No Abstract]   [Full Text] [Related]  

  • 9. [The action of D-penicillamine on the distribution of T and B-lymphocytes in rheumatoid arthritis].
    Crouzet J; Fournier C; Bach JF; Camus JP
    Rev Rhum Mal Osteoartic; 1977 May; 44(5):335-7. PubMed ID: 329400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-modifying agents in rheumatoid arthritis.
    Lipsky PE
    Ryumachi; 1987 Dec; 27(6):409-12. PubMed ID: 2455354
    [No Abstract]   [Full Text] [Related]  

  • 11. Cells with immunoregulatory function: the human macrophages and the effects of remittive drugs.
    Harth M; Keown PA; Orange J
    J Rheumatol Suppl; 1983 Dec; 11():76-80. PubMed ID: 6230447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [D-penicillamine (Artamin) as basic therapeutic agent in the treatment of chronic rheumatoid arthritis].
    Tausch G; Bröll H; Eberl R
    Wien Klin Wochenschr; 1973 Jan; 85(4):59-63. PubMed ID: 4567434
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of rheumatoid arthritis with D-penicillamine].
    Miehlke K
    Arzneimittelforschung; 1971 Nov; 21(11):1815-7. PubMed ID: 5171812
    [No Abstract]   [Full Text] [Related]  

  • 14. Good response to D-penicillamine in IgA-deficient rheumatoid arthritis.
    Mbuyi-Muamba JM; Stevens E; Dequeker J
    Scand J Rheumatol; 1981; 10(1):31-2. PubMed ID: 7221493
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of the antirheumatic agents N-(2-carboxyphenyl)-4-chloroanthranilic acid disodium (CCA) and D-penicillamine on the NK and ADCC activities and interferon production of lymphocytes.
    Ohara M; Igarashi S; Kobashi C; Nanamiya M; Yoshida H; Kasukawa R
    J Immunopharmacol; 1984; 6(3):163-72. PubMed ID: 6208286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of patients with rheumatoid arthritis in longterm administration of D-penicillamine.
    Dominkus M; Chlud K; Maida EM; Grisold W
    J Rheumatol; 1992 Oct; 19(10):1648-50. PubMed ID: 1464886
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of rheumatoid arthritis using D-penicillamine].
    Ott VR; Schmidt KL
    Internist (Berl); 1974 Jun; 15(6):328-35. PubMed ID: 4211090
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the mechanism of action of D-penicillamine].
    Klein W; Altmann H; Tausch G; Bröil H; Eberl R
    Verh Dtsch Ges Rheumatol; 1974; 3(0):88-90. PubMed ID: 4839629
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of clinical activity and D-penicillamine or gold treatment on the occurrence of serum immune complexes in patients with rheumatoid arthritis].
    Brühl W; Swierczyńska Z; Cygler B; Woźniczko-Orłowska G
    Reumatologia; 1979; 17(3):303-6. PubMed ID: 515575
    [No Abstract]   [Full Text] [Related]  

  • 20. Observations on in vivo skin elasticity and skin thickness of patients with rheumatoid arthritis treated with D-penicillamine and gold salts.
    Harvey W; Henderson DR; Grahame R
    Postgrad Med J; 1974 Aug; 50 Suppl 2():33-6. PubMed ID: 4467174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.